Che Min Chang is a pharmacist who is specialized in Oncology in Roanoke, Virginia. Patients can reach him at 1906 Belleview Ave Se, Roanoke or contact him on 718-415-9477. Active license number of Che Min Chang is 0202211486 for Oncology in Virginia. Che Min Chang is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Che Min Chang speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Che Min Chang
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Male
Location:
1906 Belleview Ave Se, Roanoke, Virginia, 24014-1838
Phone:
718-415-9477
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Che Min Chang are as mentioned below.
NPI Number:
1154700789
NPI Enumeration Date:
28 May, 2015
NPI Last Update On:
28 May, 2015
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Che Min Chang are as mentioned below.
Specialization
License Number
State
Status
Oncology
0202211486
Virginia
Primary
Oncology
5302041922
Michigan
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2768 Cricklewood Ct, Charlottesville, Virginia
Zip:
22911-8286
Phone Number:
718-415-9477
Fax Number:
--
Patients can reach Che Min Chang at 1906 Belleview Ave Se, Roanoke, Virginia or can call on phone at 718-415-9477.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.